Today's Headlines: March 21, 2019
|
|
Biological Agents & Infectious Diseases
|
|
Spike in Ebola Cases Continues in DRC
(
CIDRAP
) According to the World Health Organization's Ebola dashboard, officials today recorded 12 new Ebola cases in the ongoing outbreak in North Kivu and Ituri provinces in the Democratic Republic of the Congo. The cases bring the outbreak's total to 980 cases, including 606 deaths.
Go to article
|
|
Gavi@20: What’s Next for Global Immunization Efforts
(
Center for Global Development
) The Board of Gavi, The Vaccine Alliance, will retreat next week to discuss a new strategy and replenishment. Ahead of its 20-year anniversary next year, the Board will reflect on key questions that will frame Gavi’s mandate, funding, and activities into the next five-year period. On the agenda: questions on Gavi’s role in addressing coverage gaps in immunization, how middle-income countries should be involved, and how the organization will shape vaccine markets and future innovation.
Go to article
|
|
Scientists Rise up Against Statistical Significance
(
Nature
) When was the last time you heard a seminar speaker claim there was ‘no difference’ between two groups because the difference was ‘statistically non-significant’? If your experience matches ours, there’s a good chance that this happened at the last talk you attended. We hope that at least someone in the audience was perplexed if, as frequently happens, a plot or table showed that there actually was a difference.
Go to article
Sherlock Biosciences Licenses Wyss Technology to Create Affordable Molecular Diagnostics (
Wyss Institute) Harvard University has granted a worldwide exclusive license to Sherlock Biosciences, Inc. to develop and commercialize technology from the Wyss Institute for Biologically Inspired Engineering to create a highly sensitive, nucleic acid-based diagnostic platform that can rapidly deliver accurate and inexpensive results for a vast range of needs in virtually any setting. Named INSPECT, it was created by a team led by Wyss Core Faculty member Jim Collins, PhD, who is also the Termeer Professor of Medical Engineering & Science at Massachusetts Institute of Technology, and will be incorporated into Sherlock’s platform alongside the Broad Institute’s SHERLOC technology, which is also co-owned and licensed by Harvard University.
Go to article
|
|
Other 21st Century Threats
|
|
Victims of Chemical Terrorism, a Family of Four Who Were Exposed to Sulfur Mustard.
(
Toxicol Lett
) Sulfur mustard was responsible for more than 80% of all documented chemical casualties during the Great War. Recent literature on clinic picture of SM exposure remained so limited with the sporadic cases who were accidentally exposed to SM especially either in Western Europe or China. We reported a Syrian family of four who became victims of chemical terrorism due to SM exposure and we described the detailed clinical course of the family including the medical history, initial symptomatology, clinical examination, hematological data, and initial treatment in the first 48 hours after exposure at Kilis State Hospital, Turkey.
Go to article
|
|
Stay up-to-date with our newsletters
|
|
Published by Johns Hopkins Center for Health Security
|
|
|
|
|
|
|